Cymbalta Bottles Recalled; Suicides Highest on Mondays; New Dose of Pain Drug OK'd

— News and commentary from the psychiatry world

MedicalToday
Illustration of a brain shaped maze.

Over 7,000 bottles of the due to the potential presence of a carcinogen. (USA Today)

Pretrauma psychosocial well-being may help protect against the , researchers reported in JAMA Network Open.

In a study of 26 countries and territories, on Mondays and increased on New Year's Day in most areas. (The BMJ)

Suicide-related emergencies in minority youth and preteens, according to a review of electronic health record data. (JAMA Network Open)

Preliminary biomarker results of an ongoing phase II study of the investigational showed dose-dependent improvements in neural synchrony, thalamocortical circuits, and sensory gating, said Anavex Life Sciences.

The FDA immediate-release 10-mg tablets with abuse-deterrent technology for management of severe pain for which alternative treatments were inadequate, Protega Pharmaceuticals announced.

Could digital "avatars" be an effective ? (STAT)

A Lancet Public Health Commission on to tackle the health consequences of commercial gambling.

A panel will look into at the Psychiatric Institute of Washington. (Washington Post)

What happened to a U.S. study did not improve mental health in children with gender distress? (New York Times)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.